Range Low Price High Price Comment
30 days $0.86 $1.30 Tuesday, 30th Apr 2024 BLUE stock ended at $0.89. This is 3.93% less than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 8.88% from a day low at $0.86 to a day high of $0.94.
90 days $0.86 $1.92
52 weeks $0.86 $5.53

Historical bluebird bio prices

Date Open High Low Close Volume
Mar 08, 2016 $55.06 $55.36 $48.50 $49.00 1 506 000
Mar 07, 2016 $54.69 $57.19 $53.40 $55.12 1 160 400
Mar 04, 2016 $54.83 $59.29 $53.64 $54.50 1 868 000
Mar 03, 2016 $53.82 $56.50 $52.61 $53.87 1 213 400
Mar 02, 2016 $50.26 $54.28 $49.56 $53.86 1 912 900
Mar 01, 2016 $46.92 $50.99 $45.71 $50.51 1 887 700
Feb 29, 2016 $49.23 $50.34 $45.77 $46.22 1 102 500
Feb 26, 2016 $48.51 $49.97 $47.40 $49.73 1 267 100
Feb 25, 2016 $51.03 $52.45 $47.05 $48.15 1 430 100
Feb 24, 2016 $50.70 $52.74 $47.13 $52.37 1 261 700
Feb 23, 2016 $52.98 $54.81 $51.28 $51.46 909 800
Feb 22, 2016 $52.59 $54.95 $52.57 $53.16 917 300
Feb 19, 2016 $51.71 $52.98 $49.46 $52.05 1 143 000
Feb 18, 2016 $54.42 $54.85 $51.06 $52.10 1 073 000
Feb 17, 2016 $51.00 $55.94 $50.01 $54.24 1 870 600
Feb 16, 2016 $45.53 $50.85 $45.01 $50.13 1 635 600
Feb 12, 2016 $43.83 $45.39 $42.19 $44.55 1 573 500
Feb 11, 2016 $44.79 $45.97 $42.03 $43.32 1 375 200
Feb 10, 2016 $46.64 $48.65 $44.81 $45.99 1 248 600
Feb 09, 2016 $44.27 $49.50 $44.20 $45.79 1 987 700
Feb 08, 2016 $46.84 $47.92 $44.30 $45.63 1 594 400
Feb 05, 2016 $49.15 $49.39 $46.68 $47.73 1 553 200
Feb 04, 2016 $44.55 $50.90 $44.14 $49.28 1 919 100
Feb 03, 2016 $42.83 $45.70 $41.53 $45.30 2 159 900
Feb 02, 2016 $44.78 $45.05 $41.67 $42.37 1 545 000
Click to get the best stock tips daily for free!

About bluebird bio

bluebird bio bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clini... BLUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT